Pneumology

A Step toward Personalized Asthma Treatment

Inhaled glucocorticoids are used every day by millions of patients with asthma. As with all asthma-controller treatments, there is marked patient-to-patient variability in the therapeutic response. It would be advantageous if we could identify, in advance, patients who would respond to such treatment: Tantisira and colleagues appear to have made progress toward reaching this goal with the identification of a genetic variant associated with the response to inhaled glucocorticoids in the treatment of asthma.
Read more

 http://www.nejm.org/doi/full/10.1056/NEJMe1102469?ai=rv&af=R...

New England Journal of Medicine